The effects of mecillinam, trimethoprim and ciprofloxacin, antibiotics used in the treatment of urinary tract infections, on the aquatic environment were assessed. Mecillinam and ciprofloxacin were both readily biodegradable (primary degradation) in activated sludge, whereas trimethoprim persisted. The toxicity of these antibiotics towards sludge bacteria, a green alga, a cyanobacterium, a crustacean and a fish were investigated; both mecillinam and ciprofloxacin were highly toxic to the cyanobacterium Microcystis aeruginosa (EC 50 in the range 5-60 µg/L). Risk characterization for the aquatic environment was performed for the three compounds by calculating the predicted environmental concentration (PEC) and the predicted noeffects concentration (PNEC). A PEC/PNEC ratio of <1 indicates that, with the present pattern of use, no environmental risk is expected. PEC/PNEC ratios of <1 for present usage in Europe were found for mecillinam and trimethoprim whereas a PEC/PNEC ratio >1 was found for ciprofloxacin.
Introduction
By their nature, medicinal products, such as antibiotics, are biologically active molecules. Antibiotics are specifically designed to control pathogenic bacteria in animals and humans, but very little is known about their ecotoxicology. After administration of antibiotics to humans, a significant amount is excreted into waste water. Surplus antibiotics are also sometimes disposed of into household drains. Antibiotics therefore enter municipal sewage and sewagetreatment plants (STPs) . If the drugs are not completely mineralized in the STP, they are released into surface water or sludge and, if the sludge is used to fertilize arable land, they may enter the topsoil of fields. 1, 2 Medicinal products are licensed for use by regulatory authorities if they comply with scientific criteria on quality, efficacy and safety. The authorities consider safety to the consumer and to the individuals handling the product during treatment. In addition to these criteria, the environmental risk has recently become a matter of increasing public scrutiny and legal requirements. The risk of effects on the environment has led to regulation of new pharmaceuticals in the USA, 3 and a draft on the environmental risk assessment (ERA) of new pharmaceuticals is also proposed in the EU. 4 There are, however, no regulations or requirements concerning the environmental properties or potential effects of existing pharmaceuticals. Consequently such data are scarce.
An important step in ERA, particularly for drugs, is a cost-benefit analysis. It is necessary to know the risk to the environment and the indirect effects on the human body as a result of contamination of the environment to be able to decide whether the benefits exceed the costs. If two or more drugs have the same therapeutic effect, ERA can also be used to determine which has the lower environmental impact.
The aim of this paper is to provide data on consumption, estimated environmental concentration and the effects on the environment of three antibiotics widely used for urinary tract infections (mecillinam, trimethoprim and ciprofloxacin), enabling a preliminary comparison of their environmental hazard. The structures of these three compounds are shown in the Figure, and relevant physicochemical characteristics in Table I . The spread of bacterial antibiotic resistance genes is another pertinent effect of antibiotics on the environment. Since this is difficult to quantify and not included in the ERA assessment of antibiotics, it will not be discussed further in this paper. 
53

Environmental
Materials and methods
Chemical substances
Test substances were purchased from their manufacturers and stored at 2°C for р24 h. 
Biodegradation tests
Biodegradation tests were performed in two different test systems: (i) Oxytop respirometers (WTW, Weilheim, Germany) were used to measure biological oxygen demand (BOD) according to the guidelines published by the Organization for Economic Cooperation and Development (OECD).
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The Oxytop system is a screening system that only evaluates whether the compound is readily degradable. Sodium acetate was used as a reference compound. All compounds were tested in duplicate experiments with added concentrations corresponding to theoretical oxygen demands (ii) Biodegradation experiments with activated sludge in reactors may be used to determine the half-life of the chemical during biodegradation in the activated sludge process in a waste water system. Primary biodegradation experiments were conducted in aerated batch reactors 5 with 1 L of liquid (sludge). Experiments were conducted at 22°C and sludge was preconditioned at room temperature. Sludge was collected from the Lundtofte rensningsanlaeg sewage treatment plant, Lyngby, Denmark and maintained aerated until use, with no addition of substrate. Most sludge was used freshly collected (aeration time 1-2 h) or was preconditioned by aeration for 1 day. Laboratory reactors were fed with sludge (1 L) and mecillinam or trimethoprim 500 g/L or ciprofloxacin 250 g/L.
The biodegradation of the chemicals in the reactors was followed over time by HPLC assay. The half-life (t ½ ) in days was calculated for the primary degradation of the three compounds based on first-order kinetics. These halflives were applied in the risk assessment described below. Detailed description and validation of the HPLC methods used are available from the authors. All three antibiotics were tested in duplicate reactors. Aniline was used as a reference compound. Estimated with ACD Log P software (Advanced Chemical Development, Toronto, Canada).
Environmental risk assessment of antibiotics
Ecotoxicology
Toxicity towards the following organisms was tested: activated sludge bacteria; a green alga, Selenastrum capricornutum (eukaroytic); a cyanobacterium, Microcystis aeruginosa (prokaryotic); the zooplankton Daphnia magna; and the zebrafish, Brachydanio rerio. All toxicity tests were performed in accordance with OECD or International Organization of Standardization (ISO) guidelines.
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Risk assessment
Environmental risk assessment (ERA) was based on the EU draft guideline document for medicinal products for human use 4 and was conducted in two phases. For most medicinal products, it is anticipated that only the first phase of the evaluation will be necessary. Phase II of the ERA, which involves a comprehensive assessment of ecotoxicology, is considered when the predicted environmental concentration (PEC) exceeds a threshold value of 0.001 g/L in surface water and 10 g/kg soil. The phase II assessment involves calculation of a risk quotient between the predicted (PEC) or measured environmental concentration and the predicted no-effect concentration (PNEC), using worst-case assumptions.
For the aquatic compartment, it was assumed that all antibiotics are used in the year they are purchased; that the antibiotics are released into the environment without degradation in man or the sewage system; and that the use pattern is evenly distributed temporally and spatially. The concentration in water of the active substance (PEC w ) was calculated from the following equation:
where A is the amount used (kg/year), R is the percentage removal (set to zero when information on biodegradation in the STP is missing or when worst-case conditions are assessed), P is the population of Europe (383 million in 1999), V is the volume of waste water per capita per day (0.2 m 3 ) and D is the dilution factor in the environment (a default factor of 10 was used). A hydraulic retention time (HRT) of 10 h was used in the PEC w calculations, incorporating the degradation.
For compounds sorbing to sludge, the concentration in sludge can be calculated if the partition coefficient between sludge and water, K d , is measured or estimated based on the octanol-water partition coefficient, K ow , and the fraction of organic carbon in sludge (f oc ϭ 0.35), and calculated as follows: 
The calculation of the predicted concentration in sludge (C sludge ) is based on no degradation or other loss of the drugs. The concentration of the antibiotics in sludge can be calculated as:
10 m 3 . For the mass of sludge, M sludge , a value of 151 159 tonnes in 1997 was used for Denmark. M medicinal compound , the annual loading of antibiotic to the environmental compartment, is often assumed to equal consumption because of lack of information.
Results and discussion
Physicochemical properties of the chemicals n-Octanol-water partition coefficients were obtained from literature using the Syracuse database at http://esc.syrres. com/ and calculated using ACD log P software. No published value was found for mecillinam, but agreement between calculated and literature values for the two other substances suggests that the range of the calculated value for mecillinam is appropriate. Based on the available n-octanol-water partition coefficients, it is considered appropriate to use static exposure systems in the toxicity tests.
No values for the vapour pressure of any of the three substances were found in the literature. However, the molar weights (Ͼ200 g/mol) and the presence of several polar groups in each of the three molecules suggests that vapour pressure as well as air-water partition coefficients will be small. Therefore no special precautions were employed in the test procedure to handle loss of test substance by evaporation.
Degradation test
None of the compounds was found to sorb strongly to sludge. The partition coefficients, K d , between water and sludge for mecillinam, trimethoprim and ciprofloxacin were found to be 55, 76 and 417, respectively. Table II shows the results of the biodegradation studies performed with the Oxytop system and the activated sludge reactors. Biodegradation in the Oxytop system was very poor: all three compounds persisted for the entire 28 days of the test period. Using this system, which is considered an initial screening system, all three compounds were therefore assessed as being not readily degradable.
The next step was assessment of the primary degradation of the compounds in sludge reactors. Results performed with an initial concentration of 500 g/L of mecillinam showed that biodegradation occurred rapidly in this test system. The estimated t ½ (assuming first-order degradation) was 0.5 days for one sludge column and 0.7 days for the other. -Lactams such as mecillinam are also subject to abiotic degradation such as hydrolysis. This may speed up degradation in the STP.
Biodegradation studies performed with trimethoprim 500 g/L in the reactors showed that degradation had not reached 50% at day 25. Trimethoprim persisted in the two reactors with a t ½ of 22 days and 41 days, respectively. Ciprofloxacin 250 g/L was degraded quickly until 50% had been degraded. Its t ½ was 2.5 days in one reactor and 1.6 days in the other. This result is consistent with a similar study investigating the primary degradation of ciprofloxacin, 12 in which it was found that the t ½ for ciprofloxacin in activated sludge was between 1 and 5 days, depending on the sludge concentration. Compared with a compound like pentachlorophenol, which is recognized as barely degradable under such test circumstances [t ½ (first order model) about 5 days], trimethoprim is extremely persistent, whereas mecillinam and ciprofloxacin are readily degradable (primary degradation). Because results show that ciprofloxacin probably was not mineralized under the test conditions, more studies need to be performed on metabolites. This study and that of Hartmann and co-workers 12 indicate that compounds resembling ciprofloxacin persist in the sludge. The reference compound aniline was degraded rapidly (t ½ ϭ 0.7 days) in the reference reactor, showing the ability of the activated sludge to degrade chemical compounds. Green algae and cyanobacteria. Only ciprofloxacin was toxic to S. capricornutum (EC 50 ϭ 2.97 mg/L), whereas mecillinam (NOEC ϭ 300 mg/L) and trimethoprim (EC 50 ϭ 110 mg/L) were toxic only at environmentally irrelevant concentrations. The highest mecillinam concentration applied was 300 mg/L, so this concentration is therefore detected as the lower limit of NOEC. Both mecillinam and ciprofloxacin were highly toxic to M. aeruginosa (see Table  III) , with EC 50 s in the range 5-60 g/L. M. aeruginosa was generally much more sensitive than S. capricornutum to both mecillinam and ciprofloxacin. This is not surprising, as M. aeruginosa is a prokaryote whereas S. capricornutum is a eukaryote. Similar results have been reported for other antibiotics. 13 The EC 50 of potassium dichromate was 0. Daphnia magna. Mecillinam was tested in a limit test 7 at two concentrations, 300 and 1000 mg/L. At these concentrations it did not kill D. magna. Ciprofloxacin was tested in a similar limit test at 30 and 60 mg/L (at concentrations of Ͼ60 mg/L, ciprofloxacin crystallized and was, therefore, no longer bioavailable, so it was not tested at higher concentrations). At these concentrations, ciprofloxacin did not kill the organisms studied. Trimethoprim was tested at five concentrations between 30 and 300 mg/L. Table III shows the toxicity of the three compounds towards D. magna: trimethoprim had minor effects on D. magna.
Toxicity tests
Zebrafish. A limit test was performed in accordance with OECD guidelines 8 at two concentrations (30 and 100 mg/L) for all three compounds. For all three compounds, an NOEC (72 h) of 100 mg/L was found. Assuming that toxicity fits a probit-type effect curve, this indicates a 99.9% confidence level for the true EC 50 being Ͼ100 mg/L.
Environmental loading
Because data on environmental loading were not available for the antibiotics tested, the environmental loading was assumed to be the greatest possible, i.e. equal to the consumption of the compounds. Data for Europe (Spain, Portugal, Italy, Greece, Germany, Switzerland, France, Austria, Denmark, Belgium, The Netherlands, UK, Ireland, Norway, Sweden and Finland; total population 383 million) was obtained from IMS 14 for the first 3 months of 1999 and extrapolated to give a value for the whole of 1999. These IMS data exclude consumption at hospital level in Spain, Portugal, Greece, Switzerland and Ireland. The total environmental loading in 1999 for mecillinam, ciprofloxacin and trimethoprim was estimated as 2.0, 186.2 and 47.8 tonnes/year, respectively.
Preliminary risk characterization
Risk characterization is the estimation of the incidence of the adverse effect occurring in an environmental compartment as a result of actual or predicted exposure to a substance. It generally involves the integration of an effect assessment (calculating the PNEC) and an exposure assessment (calculating the PEC). We calculated PEC in two ways: (i) not including degradation data (worst-case scenario) (we call this PEC 1 ) and (ii) including degradation data (PEC 2 ) (Table IV) .
Many international regulatory frameworks often express risk as a PEC/PNEC ratio. It should be noted that these ratios are not absolute measures of risk.
The worst-case PEC estimations, PEC 1 (R ϭ 0 in Equation 1), for the three compounds show that (based on European consumption data) none of the three compounds exceeds the threshold values in the EU (1994) draft guideline 4 of 0.001 g/L for surface water. With today's pattern of use, the compounds would not, therefore, require phase II assessment. However, changes in the consumption pattern of the three compounds throughout Europe or in certain member countries could enhance the PEC and therefore trigger a demand for more information.
The aim of this study was to compare the environmental fate and effects of the three compounds, as part of the phase II assessment, on the aquatic environment using bacteria (activated sludge), green algae and cyanobacteria, daphnia and fish as target organisms. The terrestrial compartment was not assessed because none of the compounds was found to sorb strongly to activated sludge (K d Ͻ500) and are not used in veterinary therapy. An assessment factor of 100 was used in accordance with OECD guidelines, available. The lowest EC 50 (see Table III ) obtained for the three compounds were therefore recalculated to a PNEC of 0.0006, 0.18 and 0.00005 mg/L for mecillinam, trimethoprim and ciprofloxacin, respectively. Based on these PNECs, the PEC/PNEC ratio was calculated. Table IV shows PEC/PNEC calculations for the three antibiotics at European level, excluding the degradation data (PEC 1 /PNEC; worst-case scenario) and including these data (PEC 2 /PNEC). A PEC 1 /PNEC ratio of Ͼ1 was found for ciprofloxacin; the ratios for mecillinam and trimethoprim were both ϽϽ1. This is a result of the lower consumption of trimethoprim, even though it is assessed as the most persistent of the three compounds. The picture did not change much after taking the biodegradation of the compounds into consideration because mecillinam and trimethoprim still had PEC 2 /PNEC ratios Ͻ1, suggesting that no environmental hazard would occur with today's pattern of use. The PEC 2 /PNEC ratio was still Ͼ Ͼ1 for ciprofloxacin, identifying a possible environmental hazard with today's pattern of use. This study would suggest that more information on the fate and effects of ciprofloxacin in environmental matrices should be provided.
